Loading
IARC estimates 84 new cancer cases and 54 cancer deaths in Sao Tome and Principe in 2024; the commonest new cancers are breast, cervix uteri and prostate. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Sao Tome and Principe's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Breast | 28 | 32.9 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 14 | 17.4 | Cervical cancer |
| Prostate | 14 | 22.0 | Prostate cancer |
| Liver and intrahepatic bile ducts | 8 | 5.4 | Hepatocellular carcinoma |
| Colorectum | 5 | 3.4 | Colorectal cancer |
| Corpus uteri | 4 | 5.7 | Endometrial cancer |
| Ovary | 3 | 4.1 | Ovarian cancer |
| Stomach | 2 | 1.4 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 2 | 0.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 1 | 0.8 | Pancreatic ductal adenocarcinoma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Breast | 15 | 18.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Prostate | 10 | 15.6 | Prostate cancer |
| Liver and intrahepatic bile ducts | 8 | 5.4 | Hepatocellular carcinoma |
| Cervix uteri | 7 | 9.5 | Cervical cancer |
| Colorectum | 4 | 2.9 | Colorectal cancer |
| Ovary | 3 | 4.1 | Ovarian cancer |
| Stomach | 2 | 1.4 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 2 | 0.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Pancreas | 1 | 0.8 | Pancreatic ductal adenocarcinoma |
| Larynx | 1 | 0.8 |
No trial record in OnCo lists a site in Sao Tome and Principe. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Sao Tome and Principe.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Sao Tome and Principe is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Sao Tome and Principe is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.